FDA Approved: LEVALBUTEROL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Levalbuterol submitted by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Levalbuterol (Levalbuterol)

Snippet

SUPPL AP for LEVALBUTEROL (LEVALBUTEROL)